Vaccine shows promise against aggressive brain cancer

A new clinical trial has found that a personalized vaccine to treat glioblastoma is safe and could potentially improve outcomes.

In patients with an especially aggressive form of glioblastoma, the vaccine caused no serious side effects and prolonged patients’ overall survival compared to historical outcomes after standard-of-care surgery and chemo-radiotherapy. One ...